Mallika Purandare1, Alexa N Ehlert2, Henri Vaitkevicius3, Barbara A Dworetzky1, Jong Woo Lee4. 1. The Edward B. Bromfield Epilepsy Program, Department of Neurology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA 02115, United States. 2. Harvard T.H. Chan School of Public Health, Harvard Medical School, Boston, MA 02115, United States. 3. Division of Neurocritical Care, Department of Neurology, Brigham and Women's Hospital / Harvard Medical School, Boston, MA 02115, United States. 4. The Edward B. Bromfield Epilepsy Program, Department of Neurology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA 02115, United States. Electronic address: jlee38@partners.org.
Abstract
PURPOSE: The objective of this study was to determine if continuous electroencephalography (cEEG) results are associated with functional outcome and survival in critically ill patients with intraparenchymal hemorrhages (IPH). METHODS: Patients diagnosed with IPH were selected using a Critical Care EEG Monitoring Consortium Database at Brigham and Women's Hospital in Boston. Functional Outcome in Patients with Primary Intracerebral Hemorrhage (FUNC) scores and Intracerebral Hemorrhage (ICH) scores were calculated as covariates. Outcomes of interest were functional outcome (modified Rankin scale [mRS] <3 vs ≥3) and mortality at hospital discharge. cEEG features, as defined by the American Clinical Neurophysiology Society standard terminology, were assessed for association with outcome after accounting for known clinical covariates. RESULTS: A total of 94 patients admitted between March 2013 and December 2015 were selected. Multivariate regression analysis revealed that the presence of Stage II Sleep is independently associated with good functional outcome at discharge after correcting for FUNC (p = 0.0080) and ICH (p = 0.0088). The absence of anteroposterior (AP) gradient in an EEG is associated with increased likelihood of mortality at discharge after correcting for FUNC (p = 0.013) and ICH (p = 0.019) scores. CONCLUSIONS: cEEG measures were significantly associated with functional and mortality outcome measures in patients with IPH even after accounting for known clinical and radiological covariates. Further research is needed to determine whether prediction models are improved by inclusion of cEEG features.
PURPOSE: The objective of this study was to determine if continuous electroencephalography (cEEG) results are associated with functional outcome and survival in critically illpatients with intraparenchymal hemorrhages (IPH). METHODS:Patients diagnosed with IPH were selected using a Critical Care EEG Monitoring Consortium Database at Brigham and Women's Hospital in Boston. Functional Outcome in Patients with Primary Intracerebral Hemorrhage (FUNC) scores and Intracerebral Hemorrhage (ICH) scores were calculated as covariates. Outcomes of interest were functional outcome (modified Rankin scale [mRS] <3 vs ≥3) and mortality at hospital discharge. cEEG features, as defined by the American Clinical Neurophysiology Society standard terminology, were assessed for association with outcome after accounting for known clinical covariates. RESULTS: A total of 94 patients admitted between March 2013 and December 2015 were selected. Multivariate regression analysis revealed that the presence of Stage II Sleep is independently associated with good functional outcome at discharge after correcting for FUNC (p = 0.0080) and ICH (p = 0.0088). The absence of anteroposterior (AP) gradient in an EEG is associated with increased likelihood of mortality at discharge after correcting for FUNC (p = 0.013) and ICH (p = 0.019) scores. CONCLUSIONS:cEEG measures were significantly associated with functional and mortality outcome measures in patients with IPH even after accounting for known clinical and radiological covariates. Further research is needed to determine whether prediction models are improved by inclusion of cEEG features.
Authors: Jan Claassen; Lawrence J Hirsch; Jennifer A Frontera; Andres Fernandez; Michael Schmidt; Gregory Kapinos; John Wittman; E Sander Connolly; Ronald G Emerson; Stephan A Mayer Journal: Neurocrit Care Date: 2006 Impact factor: 3.210
Authors: Peter B Forgacs; Mary M Conte; Esteban A Fridman; Henning U Voss; Jonathan D Victor; Nicholas D Schiff Journal: Ann Neurol Date: 2014-10-24 Impact factor: 10.422
Authors: Jussara A O Baggio; Taiza E G Santos-Pontelli; Pedro T Cougo-Pinto; Millene Camilo; Nathalia F Silva; Paula Antunes; Laura Machado; João P Leite; Octavio M Pontes-Neto Journal: Cerebrovasc Dis Date: 2014-11-20 Impact factor: 2.762
Authors: Brandon Foreman; Jan Claassen; Karine Abou Khaled; Jeffrey Jirsch; Daniel M Alschuler; John Wittman; Ronald G Emerson; Lawrence J Hirsch Journal: Neurology Date: 2012-10-03 Impact factor: 9.910
Authors: Gian Marco De Marchis; Deborah Pugin; Emma Meyers; Angela Velasquez; Sureerat Suwatcharangkoon; Soojin Park; M Cristina Falo; Sachin Agarwal; Stephan Mayer; J Michael Schmidt; E Sander Connolly; Jan Claassen Journal: Neurology Date: 2015-12-23 Impact factor: 9.910
Authors: Shobhit Singla; Gabriella E Garcia; Grace E Rovenolt; Alexandria L Soto; Emily J Gilmore; Lawrence J Hirsch; Hal Blumenfeld; Kevin N Sheth; S Bulent Omay; Aaron F Struck; M Brandon Westover; Jennifer A Kim Journal: Curr Neurol Neurosci Rep Date: 2020-07-27 Impact factor: 6.030